Stock News

Trustmark National Bank Trust Department Has Boosted Holding in Amgen (AMGN) as Valuation Declined; Massachusetts Financial Services Company Has Boosted Its Re Max Hldgs (RMAX) Stake by $800,592

Amgen Inc. (NASDAQ:AMGN) Logo

Trustmark National Bank Trust Department increased its stake in Amgen Inc (AMGN) by 10.09% based on its latest 2017Q4 regulatory filing with the SEC. Trustmark National Bank Trust Department bought 1,990 shares as the company’s stock declined 2.99% with the market. The institutional investor held 21,709 shares of the biological products (no diagnostic substances) company at the end of 2017Q4, valued at $3.77M, up from 19,719 at the end of the previous reported quarter. Trustmark National Bank Trust Department who had been investing in Amgen Inc for a number of months, seems to be bullish on the $118.79B market cap company. The stock increased 1.07% or $1.89 during the last trading session, reaching $178.36. About 2.68 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since May 23, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Massachusetts Financial Services Company increased its stake in Re Max Hldgs Inc (RMAX) by 43.38% based on its latest 2017Q4 regulatory filing with the SEC. Massachusetts Financial Services Company bought 16,679 shares as the company’s stock rose 21.19% while stock markets declined. The institutional investor held 55,128 shares of the finance company at the end of 2017Q4, valued at $2.67M, up from 38,449 at the end of the previous reported quarter. Massachusetts Financial Services Company who had been investing in Re Max Hldgs Inc for a number of months, seems to be bullish on the $1.62 billion market cap company. The stock decreased 0.56% or $0.3 during the last trading session, reaching $53.6. About 139,957 shares traded or 17.13% up from the average. RE/MAX Holdings, Inc. (NYSE:RMAX) has risen 4.25% since May 23, 2017 and is uptrending. It has underperformed by 7.30% the S&P500.

Investors sentiment decreased to 1.14 in 2017 Q4. Its down 0.05, from 1.19 in 2017Q3. It turned negative, as 18 investors sold RMAX shares while 48 reduced holdings. 29 funds opened positions while 46 raised stakes. 17.83 million shares or 0.53% less from 17.93 million shares in 2017Q3 were reported. Goldman Sachs Grp Inc owns 94,353 shares or 0% of their US portfolio. Blair William & Il has invested 0.09% in RE/MAX Holdings, Inc. (NYSE:RMAX). Hsbc Holding Public Ltd holds 0% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX) for 4,136 shares. Los Angeles Management Equity Research holds 32,432 shares or 0.01% of its portfolio. Massachusetts-based Arrowstreet LP has invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). Fund Mngmt has invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). The Ohio-based Bahl Gaynor Inc has invested 0.02% in RE/MAX Holdings, Inc. (NYSE:RMAX). Principal Fincl Gru has invested 0.01% in RE/MAX Holdings, Inc. (NYSE:RMAX). Regions stated it has 0% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX). Ftb Advsrs holds 0% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX) for 117 shares. Prudential Inc has invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). Ls Inv Advsr Lc accumulated 0% or 563 shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). Teachers Retirement System Of The State Of Kentucky reported 5,800 shares or 0% of all its holdings. Acadian Asset Ltd Llc owns 590 shares.

Among 13 analysts covering RE/MAX Holdings (NYSE:RMAX), 3 have Buy rating, 3 Sell and 7 Hold. Therefore 23% are positive. RE/MAX Holdings had 21 analyst reports since August 11, 2015 according to SRatingsIntel. On Friday, December 22 the stock rating was upgraded by Compass Point to “Neutral”. The firm earned “Underweight” rating on Wednesday, March 28 by JP Morgan. The rating was initiated by Piper Jaffray on Thursday, September 28 with “Buy”. Stephens maintained it with “Hold” rating and $60.0 target in Friday, February 23 report. The firm has “Equal Weight” rating given on Wednesday, August 19 by Morgan Stanley. The rating was downgraded by JP Morgan on Friday, December 15 to “Underweight”. The rating was maintained by Piper Jaffray on Friday, February 23 with “Buy”. The firm has “Equal-Weight” rating by Stephens given on Monday, August 7. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Friday, October 6 report. As per Thursday, March 31, the company rating was initiated by Wood.

Another recent and important RE/MAX Holdings, Inc. (NYSE:RMAX) news was published by Seekingalpha.com which published an article titled: “RE/MAX’s (RMAX) CEO Adam Contos on Q1 2018 Results – Earnings Call Transcript” on May 06, 2018.

Since May 7, 2018, it had 0 insider buys, and 1 insider sale for $271,850 activity.

Massachusetts Financial Services Company, which manages about $238.56 billion US Long portfolio, decreased its stake in Monster Beverage Corp New by 88,902 shares to 3.43 million shares, valued at $217.08 million in 2017Q4, according to the filing. It also reduced its holding in Travelers Companies Inc (NYSE:TRV) by 27,801 shares in the quarter, leaving it with 12.94 million shares, and cut its stake in Ebay Inc (NASDAQ:EBAY).

Trustmark National Bank Trust Department, which manages about $2.00 billion and $911.51M US Long portfolio, decreased its stake in Spdr (SJNK) by 145,146 shares to 811,095 shares, valued at $22.35 million in 2017Q4, according to the filing. It also reduced its holding in Darden Restaurants Inc (NYSE:DRI) by 3,661 shares in the quarter, leaving it with 2,615 shares, and cut its stake in Nucor Corp (NYSE:NUE).

Since December 12, 2017, it had 0 insider purchases, and 6 selling transactions for $1.64 million activity.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The company was downgraded on Wednesday, November 1 by Argus Research. The rating was maintained by Morgan Stanley with “Overweight” on Friday, February 2. Oppenheimer maintained the shares of AMGN in report on Friday, July 28 with “Buy” rating. The company was maintained on Friday, September 22 by BMO Capital Markets. BMO Capital Markets maintained the stock with “Market Perform” rating in Thursday, October 26 report. On Thursday, October 29 the stock rating was maintained by UBS with “Buy”. The stock has “Buy” rating by Cowen & Co on Thursday, February 1. The rating was upgraded by UBS on Monday, September 7 to “Buy”. On Friday, July 21 the stock rating was maintained by BMO Capital Markets with “Buy”. Oppenheimer maintained it with “Buy” rating and $18900 target in Monday, June 5 report.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: 247Wallst.com which released: “Amgen’s Novel Migraine Treatment Gets Key Approval” on May 18, 2018, also Seekingalpha.com with their article: “Amgen’s Dim Sales Outlook Looms Over Buybacks” published on April 26, 2018, 247Wallst.com published: “Amgen Wins Another FDA Approval” on May 22, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “Expanded label for Amgen’s Repatha approved in Europe” published on May 16, 2018 as well as Streetinsider.com‘s news article titled: “Amgen (AMGN) Reports FDA Approval of Prolia (Denosumab) For Glucocorticoid-Induced Osteoporosis” with publication date: May 21, 2018.

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.23, from 0.99 in 2017Q3. It is positive, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Papp L Roy And Assocs invested in 0.32% or 9,200 shares. Cibc World Mkts has invested 0.27% in Amgen Inc. (NASDAQ:AMGN). Comerica Bank & Trust holds 278,676 shares or 0.35% of its portfolio. Pennsylvania-based Vanguard has invested 0.4% in Amgen Inc. (NASDAQ:AMGN). Moreover, Clearbridge Investments Ltd Liability Company has 1.2% invested in Amgen Inc. (NASDAQ:AMGN). Dillon & Associates has 3,539 shares. Moreover, Andra Ap has 0.16% invested in Amgen Inc. (NASDAQ:AMGN) for 40,200 shares. Of Virginia Va has invested 1.55% of its portfolio in Amgen Inc. (NASDAQ:AMGN). 325,731 were accumulated by Great Lakes Advsrs Lc. Willingdon Wealth Management has invested 0.46% in Amgen Inc. (NASDAQ:AMGN). Hillsdale Management stated it has 2,340 shares or 0.07% of all its holdings. Compton Capital Mgmt Ri invested in 0.65% or 8,718 shares. Meiji Yasuda Life Insur, a Japan-based fund reported 13,997 shares. 9,519 were reported by Amg Funds Lc. Glenmede Tru Na holds 0.73% or 1.00 million shares in its portfolio.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *